NCT06545448

Brief Summary

Percutaneous coronary intervention (PCI) has dramatically changed the treatment of obstructive coronary artery disease patients. PCI is indicated in patients with chronic coronary syndrome (CCS) symptoms unresponsive to optimized medical therapy. The American College of Cardiology Foundation and partners developed in 2009 - and updated them in May 2017 - the appropriateness criteria for PCI to support the rational use of PCI in chronic patients and to provide patients with high-quality cardiovascular care. Since then, these criteria have been applied to guide physicians and serve as metrics of the quality of care based on the best available scientific evidence. Countries like the United States and Japan already have robust studies on the topic with important repercussions on clinical practice. In Brazil, to date, there are no studies on the adequacy of PCIs in patients with CCS.

Trial Health

57
Monitor

Trial Health Score

Automated assessment based on enrollment pace, timeline, and geographic reach

Trial has exceeded expected completion date
Enrollment
1,875

participants targeted

Target at P75+ for all trials

Timeline
Completed

Started Dec 2017

Longer than P75 for all trials

Geographic Reach
1 country

1 active site

Status
recruiting

Health score is calculated from publicly available data and should be used for screening purposes only.

Trial Relationships

Click on a node to explore related trials.

Study Timeline

Key milestones and dates

Study Start

First participant enrolled

December 1, 2017

Completed
3 years until next milestone

Primary Completion

Last participant's last visit for primary outcome

December 12, 2020

Completed
3.6 years until next milestone

First Submitted

Initial submission to the registry

August 5, 2024

Completed
4 days until next milestone

First Posted

Study publicly available on registry

August 9, 2024

Completed
1.4 years until next milestone

Study Completion

Last participant's last visit for all outcomes

December 31, 2025

Completed
Last Updated

August 9, 2024

Status Verified

August 1, 2024

Enrollment Period

3 years

First QC Date

August 5, 2024

Last Update Submit

August 5, 2024

Conditions

Keywords

Coronary artery diseaseAngina pectorisAngioplastyAppropriatenessPrognosisTreatment

Outcome Measures

Primary Outcomes (1)

  • Determine the rates of elective PCI classified as appropriate, possibly appropriate, or rarely appropriate.

    Determine the rates of elective PCI classified as appropriate, possibly appropriate, or rarely appropriate based on the Appropriateness Criteria proposed by the ACC / AHA in 2017.

    Immediately following the procedure

Secondary Outcomes (2)

  • Incidence of the composite endpoint of all-cause mortality and non-fatal cardiovascular events (myocardial infarction, periprocedural stroke, or the need for new revascularization)

    12 months after the procedure index

  • Incidence of persistent or recurrent post-PCI angina or new onset/worsening heart failure

    12 months after the procedure index

Other Outcomes (1)

  • Clinical and sociodemographic predictors of rarely appropriate elective PCI

    Immediately following the procedure

Study Arms (1)

Patients undergoing elective PCI

Patients undergoing elective PCI for chronic coronary syndrome in a tertiary hospital in a single center in Brazil between 2017-2020.

Procedure: Percutaneous Coronary Intervention (PCI)

Interventions

A percutaneous coronary intervention (PCI) is a minimally invasive procedure to open blocked coronary (heart) arteries. An older name for PCI is coronary angioplasty with stenting or angioplasty for short.

Also known as: Angioplasty
Patients undergoing elective PCI

Eligibility Criteria

Age18 Years+
Sexall
Healthy VolunteersNo
Age GroupsAdult (18-64), Older Adult (65+)
Sampling MethodNon-Probability Sample
Study Population

Patients within the age range who underwent elective PCI indicated their own physicians. This procedure was defined as an outpatient scenario or an inpatient in a non-acute setting when the Heart Team was called to evaluate the patient and agreed with the indication for PCI.

You may qualify if:

  • All patients within the age range who underwent elective PCI defined as a procedure indicated in an outpatient scenario or an inpatient in a non-acute setting when the Heart Team was called to evaluate the patient and agreed with the indication for PCI

You may not qualify if:

  • History of acute coronary syndrome \< 30 days of the referral for PCI

Contact the study team to confirm eligibility.

Sponsors & Collaborators

Study Sites (1)

Heart Institute (InCor-HCFMUSP)

São Paulo, São Paulo, 05403000, Brazil

RECRUITING

MeSH Terms

Conditions

Coronary Artery DiseaseAngina Pectoris

Interventions

Percutaneous Coronary InterventionAngioplasty

Condition Hierarchy (Ancestors)

Coronary DiseaseMyocardial IschemiaHeart DiseasesCardiovascular DiseasesArteriosclerosisArterial Occlusive DiseasesVascular DiseasesChest PainPainNeurologic ManifestationsSigns and SymptomsPathological Conditions, Signs and Symptoms

Intervention Hierarchy (Ancestors)

Endovascular ProceduresVascular Surgical ProceduresCardiovascular Surgical ProceduresSurgical Procedures, OperativeMinimally Invasive Surgical ProceduresCatheterizationTherapeuticsInvestigative Techniques

Central Study Contacts

Luis Henrique W Gowdak, MD, PhD

CONTACT

Sara DV Ziotti, MD

CONTACT

Study Design

Study Type
observational
Observational Model
COHORT
Time Perspective
RETROSPECTIVE
Sponsor Type
OTHER
Responsible Party
SPONSOR

Study Record Dates

First Submitted

August 5, 2024

First Posted

August 9, 2024

Study Start

December 1, 2017

Primary Completion

December 12, 2020

Study Completion

December 31, 2025

Last Updated

August 9, 2024

Record last verified: 2024-08

Data Sharing

IPD Sharing
Will share

There is no formal plan yet, but our team will consider any suggestions for a joint study.

Shared Documents
STUDY PROTOCOL, SAP, CSR
Time Frame
5 years from the first publication
Access Criteria
By e-mail only

Locations